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Introduction
Attention Deficit Hyperactivity Disorder (ADHD) is a
neuropsychiatric condition, characterized by endur-
ing and pervasive symptoms of inattention, hyperac-
tivity and impulsivity [28]. Stimulant medication
(particularly methylphenidate) is a common and ac-
cepted form of treatment for ADHD. Methylphenidate
has also proved to be very safe and generally well
tolerated, and professional guidelines are available for
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j Abstract Objective To exam-
ine the prevalence of the use of
health care services and psycho-
tropic medication within a com-
munity sample (N = 283) of 9-
year-old school children and,
more specifically, to evaluate the
use of prescribed stimulants.
Methods Data from the second
follow-up phase of the ‘‘Study of
Attention Deficit Maastricht’’
(SAM) were analysed. Assess-
ments at age 9 included a struc-
tured psychiatric interview with
parents, behaviour and family
situation questionnaire, IQ esti-
mate and global assessment scale.
Use of health care services and
medication was obtained by the
DICA-R and from the Youth
Health Care records. Results
About 190 children of the selected
sample had at least one child
psychiatric diagnosis, 26 (14%) of
them were clinically referred and
12 (6%) received stimulants. Of
the children with ADHD
(N = 45), 10/45 (22%) received
stimulants. Conversely, 2 out of
12 children who were treated with
stimulants did not meet full DSM-
IV diagnostic criteria, but were
subthreshold ADHD cases. The
treatment status was highly
dependent on being clinically
referred. Conclusion The major
finding of our survey is a lack of
referral to child mental health
services, and associated underdi-
agnosis and undertreatment, par-
ticularly in children with ADHD.
There is a critical need to trans-
late and implement the diagnostic
and treatment guidelines to clin-
ical practice.
j Key words ADHD –
health care services –
psychotropic medication –
epidemiology
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determining optimal dosage levels and avoiding side
effects [6, 7, 28]. However, the use of stimulant
medication for the treatment of ADHD has not been
without controversy. Concerns have been raised
about overprescription of medication and potential
abuse of stimulant medication [10, 35]. The pre-
scription of stimulant medication for children with
ADHD has significantly increased in the last decade
[19]. This increase is probably due to a number of
factors, including an increase in public and clinical
awareness and acceptance of ADHD as a disorder, a
broadening of the diagnostic criteria for ADHD and
an increase in the availability of ADHD-specific ser-
vices, particularly pediatric and child psychiatric
services [9]. Sceptics however, argue that the increase
indicates an inappropriate use of stimulants. In the
United States, the number of children who receive
stimulants increased approximately 2.5-fold in the
first half of the 1990s [19]. The scarce research liter-
ature available outside the United States confirms this
trend. A drug utilization study based on computerized
pharmacy dispensing records was conducted from
1995 to 1999 for children aged 0 to 19 years in the
north of the Netherlands also found a 2.5-fold in-
crease [23]. In Australia, about 5300 children (age 0–
17 years) started on stimulants for the first time in
2000 and this was 5 times the number in 1990 [20]. A
German study showed that during the 1998–2000
period the number of methylphenidate prescriptions
increased two and a half times [33]. These surveys
were database driven and do not permit validation of
the correctness of the diagnosis, thus precluding
inferences about the appropriateness of the use of
medication. Three studies have examined ADHD in
an unbiased community-based design. In an Ameri-
can population of youth aged from 9 to 17 only 1 in 8
children with ADHD received stimulant treatment,
but 50% of the children who were prescribed a
stimulant did not meet diagnostic criteria for ADHD
[10]. A similar result was found in an Australian
population (aged 6–17) where 12.6% of the ADHD
children received stimulants treatment and 23% of the
children used stimulants without meeting the criteria
for ADHD [21]. In the Great Smoky Mountains Study
[3] 52.9% of the ADHD or ADHD-NOS children (9–16
years old) received stimulant treatment, but 51.2 % of
the children who were prescribed a stimulant did not
have any ADHD symptoms. These studies suggest a
trend in the United States and Australia from the
perspective of ‘‘evidence-based medicine’’ towards
inappropriate use of stimulants, with undertreatment
of children diagnosed with ADHD and overprescrib-
ing of stimulant medication in the group of children
without ADHD. In Europe, no studies exist that
examine the relationship between diagnostic correct-
ness and the use of stimulants. A German study based
on health insurance data gives little evidence for
overtreatment because about two-thirds of the ADHD
children did not receive drug therapy [24].
In this article we want to investigate the use of
health care services and psychotropic medication in a
community sample of 9-year-old schoolchildren, and,
more specifically, the treatment status of ADHD
children in a non-clinical Dutch population. This
study is part of a large research program entitled
‘‘Study of Attention Disorders in Maastricht (SAM)’’.
In a school-based prospective study the precursors of
ADHD were investigated in children aged 5–6 [12, 14].
A multi-phase, screening-stratified sampling design
was used [26] and the follow-up phase at age 9 was
examined.
Method
j Subjects and procedure
Phase 1: Children enrolled at about 6 years of age
The methodology has been reported in detail else-
where [11]. This study was approved by the Ethics
Committee of the Maastricht University (Fig. 1). All
parents of a school-based population of 2,290 chil-
dren were approached with regard to participation.
All the children were enrolled in the kindergarten
(N = 65) (year before the first grade of elementary
school) in the Maastricht area, in the southern
Netherlands. The parents of 1,317 (57.5%) children
(669 boys and 618 girls, age mean ± SD 5.87 ± 0.41
year) agreed to participate and written informed
consent was obtained for phases 1 and 2. Parents did
not have to explain why they refused participation.
No significant differences were observed between the
1,317 children who participated and the 973 children
who did not in terms of age, gender and demo-
graphic factors [14]. Kroes et al. (1999) generalized
the estimated prevalences of psychiatric disorders to
an entire population and found no substantial dif-
ferences. In the first stage the parents of all 1,317
children completed the Child Behaviour Checklist
(CBCL) [1, 31] and a questionnaire on sociodemo-
graphic characteristics.
Phase 2: First follow-up at 7 years of age
On the basis of CBCL scores in phase 1, three groups
of children (in total N = 452) were selected for follow-
up. The first, an externalizing high-risk group, con-
sisted of 173 children with scores on the CBCL
broadband externalizing scale above the 90th per-
centile (T > 63) and/or scores on the inattention scale
of the CBCL above the 95th percentile (T > 67). The
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second, an internalizing high-risk group, consisted of
59 children with scores on the broadband internaliz-
ing scale of the CBCL above the 90th percentile
(T > 63) and who did not meet the selection criteria
for the externalizing high-risk group. The cut-off
points chosen represent the clinical cut-off scores for
the CBCL broadband and inattention scales deter-
mined in earlier Dutch epidemiological studies [31].
Finally, a control group of 220 children with CBCL
total scores below the 90th percentile who did not
meet selection criteria for the two high-risk groups
was selected. These children were matched with the
children of the two high-risk groups in terms of age,
gender and geographic area (urban versus rural).
The parents of all children were invited to partic-
ipate in structured psychiatric interviews (see below).
Parents of 403 (89%) children (233 boys and 170 girls,
age 7.1 ± 0.42 year) agreed to participate. Among
these were 150 (87% from initial group) from the first
group, 54 (91% from initial group) from the second
and 199 (90% from initial group) from the third
group of control children. A teacher report form
(TRF) was completed by the teachers of all children.
The participating and non-participating children did
not differ in terms of CBCL scores, gender or demo-
graphic characteristics.
Phase 3: Second follow-up at 9 years of age
When the children were 9 the parents of the three
groups of children were asked for written consent to
continue participation, which included a structured
psychiatric interview and an overall functioning
evaluation using the Children’s Global Assessment
Scale (CGAS) and a cognitive functioning estimation
of the child.
In total 283 (63% of the selected sample) parents
and children (163 boys and 120 girls, age 9.2 ± 0.4
year) took part. Among these were 107 (62% from
initial group) from the first group, 33 (56% from initial
group) from the second and 143 (65% from initial
group) controls. The 169 (36%) non-participating
children did not differ from the participating children
in terms of psychiatric diagnosis at age 7, age, gender
and demographic factors.
j Measures
The Child Behaviour Checklist (CBCL) and the Tea-
cher Report Form (TRF) [2] were completed by par-
ents and teachers when the children were 6 (CBCL), 7
(TRF) and 9 (TRF) years old respectively. The CBCL
and TRF were computer scored, using appropriate age
and gender norms for the Dutch population [5, 31].
Demographic information. When the children were
6, the level of parental occupation was scored on a 7-
point scale, ranging from unskilled to graduate/pro-
fessional, and was divided into three levels for the
present study: low (1, 2 and 3), middle (4 and 5) and
high (6 and 7) [29]. Other demographic information
included the parents’ country of birth, family intact-
ness (child living with one versus two parents),
number of siblings and residential area (urban area of
Maastricht versus surrounding villages).
The Diagnostic Interview for Children and Adoles-
cents (DICA-R) [18] in its Dutch version (Amsterdam
Diagnostisch Interview voor Kinderen—ADIKA) [13]
School-based Year Cohort 
N=2290 
Responders
N=1317 
CBCL Selection 
 At about 6 Years 
N=452 
CBCL Externalizing 
High Risk 
N=173 
CBCL Internalizing 
High Risk 
N=59 
Follow-up  
At about 7 Years 
N=403 
ADIKA 
N=150 
ADIKA 
N=54 
Control Group 
N=220 
ADIKA 
N=199 
ADIKA 
N=107 
ADIKA 
N=33 
ADIKA 
N=143 
Follow-up  
At about 9 Years 
N=283 
Fig. 1 Sampling design for the ‘‘Study of Attention
Disorders in Maastricht’’
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was used for structured psychiatric assessment of the
children at 7 and 9 years of age. The DICA-R is based
on the criteria of DSM-III-R (American Psychiatric
Association, 1994) and was adapted to the criteria of
DSM-IV (American Psychiatric Association, 1994) for
diagnosing ADHD [30]. Although no reliability stud-
ies have been performed with the ADIKA, the DICA-R
has been described recently as a useful measure in
both research and clinical settings for providing
reliable psychiatric information about children [29].
The DICA-R was administered to the parents of 7-
year-old children by three (a medical doctor, a psy-
chologist and a health care worker) and of 9-year-old
children by two (a child psychiatry trainee and a
psychologist) different interviewers, who had received
prior training. We chose to optimize reliability by
intensive supervision of the interviewers by the child
psychiatrist. To reach consensus and improve the
reliability and validity of our diagnosis, the results
were discussed weekly during an intensive supervi-
sion session of the interviewers by the research child
psychiatrist (J.S.). Discrepancy in scoring was re-
solved by consensus. When questions arose, parents
were reassessed for further clarification.
All interviewers were blind to the results of prior
assessments. The DICA-R assesses symptoms of axis-I
psychiatric disorders, such as disruptive, emotional,
anxiety and elimination disorders, and their duration,
impairment and possible consultation with health
professionals. Diagnoses were generated by a com-
puter algorithm that ignores the hierarchical DSM
structure. For example, Oppositional Defiant Disorder
(ODD) and Conduct Disorder (CD) could be diag-
nosed in the same patient.
The ADHD module of the Dutch DICA-R contains
10 questions about inattention and 11 about hyper-
activity and impulsivity. Positive answers were used
to compute the number of inattention symptoms
(range 0–10) and the number of hyperactivity and
impulsivity symptoms (range 0–11). The Dutch
DICA-R includes 4 binary items on impairment:
problems at home, problems at school, social prob-
lems and overall performance. An impairment sum
score was derived (range 0–4) from these items. An
ADHD diagnosis was generated when the DSM-IV
criteria for ADHD were present with at least 6
hyperactive and impulsive symptoms and/or inat-
tention symptoms, 2 positive scores on impairment
and an age of onset before the age of 7. When an
ADHD diagnosis was reached, the ADHD subtype was
based on a threshold score (min. 6) for the 2 symptom
groups
Intelligence at age 9 was estimated with the
Vocabulary and Block Design subtests of the WISC-R
[15]. The children were tested at school by three
psychology students and a child psychologist. They
had been extensively trained in the assessment.
The Children’s Global Assessment Scale (CGAS), a
measure of overall severity of disturbance, is an
adaptation of the Global Assessment Scale for adults
[25]. The CGAS was completed at age 9 at the end of
the interview by the interviewer. Information ob-
tained during the interview was accomplished with a
non-structured interview about the functioning of the
child at home, at school, with friends and during
spare time. To optimize the reliability of the scoring,
the results were discussed weekly during an intensive
supervision session of the interviewers by the child
psychiatrist (J.S.).
Information on the treatment or services was col-
lected in two different ways. First the DICA-R con-
tains a question about services used and medication
taken for each positively scored diagnosis. Secondly,
information was collected by the Youth Health Care
(YHC) Service. This national organization is respon-
sible for performing a periodic systematic health
examination for all children in the region. The re-
sponse rate is 98%. School doctors perform this
examination and they are allowed, by law, to use the
medical information gained anonymously for epide-
miological research purposes. The information ob-
tained by the interview was in all cases similar to the
YHC files. Only YHC information was available for the
children not reaching a threshold diagnosis.
Subjective Family Burden and Assessment of
Educational Situation was measured by a Dutch
questionnaire, the Nijmegen Family Situation Ques-
tionnaire (NVOS). The reliability and validity are good
to excellent [34]. The Subjective Family Burden exists
of 46 items resulting in 8 categories: acceptance of the
educational situation, coping capacity, having prob-
lems with the child, wanting a different educational
situation, child is burden, being on one’s own in the
educational situation, enjoying education and having
good contact with the child. Each item is scored from 1
to 5, with a low score indicating a positive response and
a high score indicating a problematic situation. The
score for each category is the average of the corre-
sponding items. The norm score for a clinically referred
population varies between 2.13 and 2.68 (2.4 ± 0.3) for
the different categories and for a control group between
1.4 and 2.01 (1.7 ± 0.3). As regards the educational
situation, parents can make a choice out of 8 descrip-
tions of the current educational situation, with the
highest score indicating that there are no problems and
no need for educational support, and the lowest score
indicating that there are severe problems, parents are
desperate and urgent help is necessary. The norm score
for a clinically referred population is 4.07 and for a
control group 2.07.
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j Statistical procedures
Explorative analysis was performed for all variables
using bivariate and multivariate tests. The Pearson v2
test (v2) and the Fisher exact two-sided test (FE) were
used for the nominal variables. The Wilcoxon rank
sum test (W) and Kruskal–Wallis test (KW) were used
for continuous variables that were not normally dis-
tributed. Logistic regression was used to obtain odds
ratios with the Wald confidence limits (OR 95% CI).
Because analyses were exploratory rather than
hypothesis-driven we did not correct for multiple
testing. We used 0.05 as threshold of statistical sig-
nificance.
Results
j Child and family demographic characteristics at
age 9 as a function of the DICA-R diagnostic
status
In Table 1 we present the child and family demo-
graphic characteristics for the 283 participating
children at age 9 as a function of the DICA-R
diagnostic status: ADHD (n = 45), other diagnosis
(n = 145) and no diagnosis (n = 93). The other
diagnosis includes other disruptive behaviour dis-
orders, mood disorder, elimination disorder and
pervasive developmental disorder. The criteria for
simple phobia are not age specific and result in an
overestimation of anxiety disorder at this age [14],
so more than two anxiety disorders had to be
present. Of the children interviewed, 14.9 % were
regarded as having DSM-IV ADHD. As we used a
design that oversampled children with ADHD be-
cause of selection based upon CBCL externalizing
group, this percentage is not representative for the
general population. At age 7 Kroes et al. (2001)
found an ADHD prevalence of 3.8% for the entire
(N = 2290) population.
The age at baseline was about 6, with the ADHD
group containing slightly older children than the 2
other groups (KW 7.0 df = 2, P = 0.03). Boys were
over represented in the ADHD group (77.8% versus
57.9 % in the other diagnosis group and versus 48.4%
in the no diagnosis group, v2 10.7 df = 2, P = 0.005).
Two family demographic characteristics distinguish
the different groups. The first, intactness of the family
was overrepresented in the no diagnosis group (93.5
vs. 80% in the ADHD group and 78.6% in the no other
diagnosis group, v2 = 9.8 df = 2, P = 0.007). Sec-
ondly, parents of the no diagnosis group tend to be
more highly qualified than parents of the other groups
(KW = 14.7 df = 4, P = 0.005). The other sociode-
mographic variables did not distinguish between the
three groups.
j Use of services
In Table 2 we present data on the major types of
services provided for the 283 participating children at
age 9 as a function of the DICA-R diagnostic status:
ADHD, other diagnosis and no diagnosis. Only 30/283
(10.6%) of the study population had ever been clini-
Table 1 Child and family
demographic characteristics
according to the ADIKA diagnostic
status
ADHD
(n = 45)
Other diagnosis
(n = 145)
No diagnosis
(n = 93)
Mean s.d. Mean s.d. mean s.d. Kruskal–Wallis
Age at baseline 6.1 (0.5) 5.9b (0.4) 5.8b (0.4) 0.03
CBCL at 6 years
Total 66.4 (9.4) 56.5b (11.7) 48.6bc (11.5) <0.0001
Internalizing 59.1 (9.4) 55.7b (11.3) 48.1bc (10.1) <0.0001
Externalizing 65.4 (10.9) 56.4b (11.7) 49.9bc (11.0) <0.0001
Inattention Scale 65.5 (9.4) 56.1b (6.9) 53.2bc (5.3) <0.0001
n % n % n % Chi-square
Gender boys 35 (77.8) 48b (57.9) 45b (48.4) .005
Urban 31 (68.9) 98 (67.6) 52 (55.9) .14
Intact family 36 (80) 114 (78.6) 87bc (93.5) .007
Immigrant parents 4 (9.3) 18 (12.6) 11 (12.1) .84
Education parentsa .005
Low 27 (60) 64 (45.4) 28b (30.1)
Average 12 (26.7) 34 (24.1) 27b (29.0)
High 6 (13.3) 43 (30.5) 38b (40.9)
a4 missing in the No diagnosis group
bSignificantly different at .05 from high risk externalizing
cSignificantly different at .05 from high risk internalizing
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cally referred for psychosocial or behavioural prob-
lems. This referral could be to a paediatrician (n = 1),
child neurologist (n = 8), or a child psychiatrist
(n = 22). Some children were referred to more than
one medical doctor. Children were 7.1 (95% CI 2.9–
17.1) times more likely to be referred for ADHD
behaviour (n = 16 or 5.6%) than for other psycho-
pathology (n = 10 or 3.5%) (FE, P = 0.03). This trend
was not present for other types of services such as
school services or psychosocial treatment. In the
ADHD group 5 children versus 10 in the other psy-
chopathology group received school services (FE,
P = 0.15) and 6 children versus 8 (FE, P = 0.06) re-
ceived psychosocial treatment.
j Use of medication
Methylphenidate was the only prescribed stimulant
treatment in this cohort. At age 7, none of the chil-
dren received stimulant medication. At age 9, 12
children or 4.2% of the follow-up study population
receive stimulant medication. Medication was initi-
ated in 11 children after clinical referral, and only one
child received medication after contacting the general
practitioner (GP). Ten children had a DICA-R diag-
nosis of ADHD, 1 child with an emotional disorder
and one child with no diagnosis at all. Two children
with a positive ADHD diagnosis received both ther-
apies (medication and psychosocial treatment).
Thus, 2 out of 12 (16.6%) of the children on
stimulants did not meet full diagnostic criteria for
ADHD. This group is too small to draw strong con-
clusions, but some individual descriptions can be
made. Both children have subthreshold or borderline
ADHD. They have threshold ADHD symptom scores
but low impairment scores. They have poor results on
the WISC-R but were going to a normal school, had
average to highly educated parents, and the teacher
scored average to high on the TRF.
Within the ADHD group 30/45 (66.7%) of the
children did not receive any kind of therapy, 10
(22.2%) received monotherapy and 5 (11.1%) received
combined therapy. Looking at the different kinds of
therapy, 10 (22.2%) received stimulant medication, 5
(11.1%) special school services and 6 (13.3%) psy-
chosocial treatment. Only one child, diagnosed with
autism, received a non-stimulant medication (pip-
amperone).
The average dose of methylphenidate was about
22.5 ± 8.6 mg/day and there was no dependence on
the ADHD diagnostic status.
To evaluate the rationale for stimulation treatment,
two different subgroups were formed. The first group
included the children with ADHD who were treated
with stimulants (n = 10), the second group the children
with ADHD without stimulant treatment (n = 35).
j Influence of Demographics, ADHD Characteristics,
Comorbidity and Educational Situation on
Stimulant Treatment Status
As expected, the main difference between these two
groups was the percentage of children clinically re-
ferred (90 vs. 20%, FE, P < 0.001) (Table 3).
Furthermore, the ADHD children on stimulants,
compared with those without stimulant use, had
higher total scores on the TRF at age 7, (mean ± SD
62.0 ± 12.6, versus 56.2 ± 8.4, W, P = 0.3), had more
inattentive symptoms of ADHD as obtained by DICA-
R (8.2 ± 1.1 vs. 7.1 ± 1.8, W, P = 0.05), had more
frequent comorbid conduct disorder (40 vs. 11.4%,
Fisher exact test, P = 0.06) and had less frequent co-
morbid oppositional defiant disorder (20 vs. 60%, F,
P = 0.03). No differences between the two groups
were found in regard to gender, residential area,
family intactness, parental education, prorated scores
of the WISC, CBCL scores at age 6, CGAS, the dis-
tribution of ADHD subtypes, the ADHD impairment
score and comorbidity with anxiety and mood dis-
orders.
We also explored whether ADHD children treated
with stimulants differed from those without stimu-
lants in terms of subjective family burden, educa-
tional situation and need for health care services. Both
ADHD groups had high scores for subjective family
burden, which were consistent with the norm scores
for clinically referred populations (between 1.6 ± 0.4
and 3.2 ± 0.8 for the different categories). Similar
results were obtained for the educational situation,
where both ADHD groups scored within the clinical
Table 2 Numbers of children
receiving types of services by ADIKA
diagnostic status
ADHD
(n = 45)
Other diagnosis
(n = 145)
No diagnosis
(n = 93)
Total
(n = 283)
n % n % n % n %
Clinically Referred 16 (35.6) 10 (6.9) 4 (4.3) 30 (10.6)
Stimulants 10 (22.2) 1 (0.7) 1 (1.1) 12 (4.2)
Other medication 0 (0) 1 (0.7) 0 (0) 1 (0.3)
School services 5 (11.1) 10 (6.9) 6 (6.4) 21 (7.4)
Psychosocial treatment 6 (13.3) 8 (5.5) 2 (2.1) 16 (5.6)
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range (3.7 ± 1.2 vs. 3.6 ± 1.8). However, the sub-
jective family burden and assessment of the educa-
tional situation did not differ between ADHD children
with or without stimulant treatment.
Discussion
To the best of our knowledge, this survey is the first
European study examining the relationship between
ADHD status and the clinical referral and treatment
status including the use of psychotropic medication in
a non-clinical sample of ADHD children.
Since the start of the discussion about the question
of over versus undertreatment of ADHD [10], sceptics
have argued that only community-based epidemio-
logical surveys within a well-defined sampling frame
and rigorous diagnostic procedures can yield mean-
ingful estimates of treated and untreated prevalence
rates of ADHD. These diagnostic procedures must
include the information of different informants so
that the presence of the ADHD symptoms can be
evaluated in more than one setting. In this project, we
have tried to achieve this by using a semi-structured
interview of the parent with specific questions about
the onset of the symptoms and the impairment in
different settings such as home, school, friends and
overall functioning. The CBCL and TRF behaviour
questionnaires were completed by the parents and
teachers at different ages, together with specific child
and family characteristics such as IQ, CGAS, sub-
jective family burden and assessment of the educa-
tional situation. As such, we were able to validate the
DICA-R based diagnoses at subgroup level by ques-
tionnaire data completed by parents and teachers.
Despite the methodological limitation in respect of
generalizing our results to an entire population, the
relation between ADHD status and mental health
support generates some interesting hypotheses, which
we will discuss further in this section.
We conducted our survey in a cohort of school-
children all of the same age. At the time of the data
collection (1999–2000) the children were about 9–10
years old, when ADHD is most prevalent [17, 27].
Another important issue is the short study’s sampling
period (8 months) and the fact that information on
the prescription of medication was attached to the
period of 12 months just before the interview. Since
we did not want to rely just on the parents for the
information about prescribing psychotropic medica-
tion, information was also collected by Youth Health
Care (YHC) Service. In this way additional informa-
tion was collected with exact start and end dates of
medication, together with the doses and the pre-
scriber.
Our study shows a discrepancy between DICA-R
diagnosis and the use of medical health care services.
Only 13.7% of the children with an eventual child
psychiatric diagnosis had been clinically referred in
the 12 months before the interview. This figure was
higher (35.6%) for the ADHD group. It would be
Table 3 Characteristics among
children with/without stimulant
treatment
ADHD + Stimulant+
(n = 10)
ADHD + Stimulant)
(n = 35)
n % n % Fisher exact
Gender boys 10 (100) 25 (71.4) 0.08
Clinically referred 9 (90) 7 (20) 0.001
Comorbidity
ODD 2 (20) 21 (60) 0.03
CD 4 (40) 4 (11.4) 0.06
Mood disorder 5 (50) 24 (68.6) 0.4
Anxiety disorder>2 4 (40) 11 (31.4) 0.7
Enuresis 3 (30) 8 (22.9) 0.7
Mean s.d. Mean s.d. Wilcoxon
TRF at age 7
Total 62.0 (12.6) 56.2 (8.4) 0.03
Externalizing 63.0 (11.6) 55.7 (9.9) 0.08
Internalizing 55.8 (12.7) 50.8 (10.4) 0.3
Inattention scale 63.7 (10.1) 57.0 (6.6) 0.09
ADHD criteria
Inattentive items 8.2 (1.1) 7.1 (1.8) 0.05
Hyperactive & impulsive items 8.5 (2.7) 6.8 (3.1) 0.09
Impairment 3 (0.8) 2.9 (0.8) 0.8
Age of onset 3.1 (2.2) 2.8 (2.0) 0.9
CGAS 56.2 (6.5) 58.1 (7.6) 0.7
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interesting to investigate the factors influencing the
referral and treatment status. Several studies have
been done to investigate the concordance between the
psychological diagnosis by a general practitioner (GP)
and parent reports of psychological problems. A
London study [22] showed that only a third of parents
of 5 to 11 year olds who had concerns expressed them
during the consultation. In a general population
sample of 2,449 Dutch children and adolescents (4–
17 years old) [36] the concordance between psycho-
logical diagnoses by the GP and parent, teacher and
adolescent reports of psychological problems was
limited. Strong recommendations were made to in-
crease GP identification of child psychological prob-
lems and enhance access to care for those in need.
Our results support these recommendations, but the
study design limits the generalization.
At the time of the data collection (1999–2000) the
dramatic increase in prescribing methylphenidate in
the Netherlands had occurred [23], but the use of
psychotropic medication within an at-risk population
still remains low. Only 4.2 % of our follow-up study
population used stimulants—all methylpheni-
date—and only one child (0.3%) used other psycho-
tropic medication. Of the children with an ADHD
diagnosis, only 22.2% received stimulants.
Because of the different design of epidemiological
studies on the use of stimulants, it is difficult to com-
pare our results with other studies. Important differ-
ences are the age of the child under study, the use of
DSM IV, the short study’s sampling period and the time
of collecting the data (1999–2000). Nevertheless, our
results are congruent with the findings of Jensen (1999)
in an American population and Sawyer (2002) in an
Australian population with about 1 in 8 children with
ADHD receiving medication. In our study, we found
few arguments for the group with stimulant treatment
being less impaired than the group without stimulant
treatment. Parents of both groups have a serious need
for health care services. Both impairment and CGAS
scores indicated serious impairment in all the ADHD
children. Possible protective factors such as sociode-
mographic or educational characteristics or absence of
comorbidity were found unable to explain the treat-
ment versus non treatment status of the ADHD chil-
dren. They support the idea that undertreatment of
ADHD is the predominant problem.
A next and related issue is whether the treatment
offered is adequate. The average dose of methylphe-
nidate in our study was about 22.5 ± 8.6 mg/day. This
dose is comparable to the average dose at baseline in
the community part (23 mg daily) of the MTA study
[16]. The MTA study showed that the titration pro-
tocol for optimal treatment effect of methylphenidate
resulted in higher doses [32]. We have no information
on the effect of the medication in our sample, but it
could be interesting to evaluate the effect of the pro-
tocol in this population. Extrapolating from the MTA
study, our data suggest that the prescribed dosages of
methylphenidate were suboptimal.
Factors influencing the medication status in the
present study were the number of inattentive symp-
toms and the absence of comorbidity with ODD. The
groups were too small to investigate the distribution
of subtypes of ADHD. The subjective family burden
and the educational situation seemed to have no
influence on this result, but the recognition of the
problems by the teacher was highly significant. The
treated and untreated ADHD group experienced the
same burden and both achieved the norm score for a
clinical population, indicating that medication was
necessary and undertreatment was present also for
the untreated ADHD group. Questions arise as to
whether the subjective family burden and the educa-
tional situation are good measures for the need for
psychopharmacological treatment. One study exam-
ined ADHD and parental psychological distress with
respect to the medication status of children with
ADHD [8]. The introduction of medication status in
the multiple regression analyses did not significantly
influence parental stress. This suggests that subjective
family burden may be associated more with ‘‘learned
helplessness’’ than with the child’s behaviour [8].
The most important factor influencing the medi-
cation status was being clinically referred. Almost all
the children with stimulant treatment were referred
compared with only 20% of the ADHD children
without stimulant treatment. This correlation could
be expected because referral is necessary to obtain
medication. ADHD behaviour was more related to
clinical referral than other psychopathology, but other
patterns determining the referral status remain un-
clear. Further work is needed on parental and child
behaviour characteristics before any conclusion can
be drawn. We will focus on this in a future report.
Two of the 12 children receiving stimulants (i.e.
16.6%) did not meet the full diagnostic criteria for
ADHD. They had threshold ADHD symptoms on at
least one symptom cluster but without impairment.
Of these, one child was diagnosed with an emotional
disorder and one child had no diagnosis at all. We
have reason to believe that the use of stimulants in
these cases is not totally inappropriate. Another
consideration is the effect of treatment resulting in the
disappearance of the symptoms and underscoring on
the DICA. Angold (2000) however investigated this
topic and concluded that low symptom score cannot
be accounted for by the curative effect.
The methods in this study design were well worked
out and a 2-stage screening design was used. Two-
stage designs frequently result in wide confidence
intervals, so that results have to be interpreted pru-
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dently. The data did not suggest selective attrition and
the drop-out rate was about similar to that of a
comparable study [4]. Nonetheless, because of the 2-
stage screening design it is difficult to estimate to
what extent these results can be generalized to an
entire population. The drop-out rate could be influ-
enced by the treatment status and biases the results in
both ways. Furthermore, although the children were
recruited from a large primary school population
(N = 1317), it should be acknowledged that the
prevalence of ADHD diagnoses would have been lar-
ger if children from special schools for primary edu-
cation had been included. These results should
therefore be replicated in other samples.
The recent findings of the MTA study and the
European Clinical Guidelines for hyperkinetic disor-
der indicate that for pervasive and severe disabling
ADHD stimulant medication is more powerful than
behaviour treatment alone. With respect to this rec-
ommendation, the availability of medication for
ADHD children whose problems are severe should be
a major concern. Based on our survey, we have
few reasons to conclude that overtreatment with
stimulants is a major problem in this region of the
Netherlands. Undertreatment and low rates of clinical
referral to child mental health services of children
who are impaired by their ADHD symptoms seems to
be one of the major findings of our survey. Research
is needed to elucidate the most common pathways
leading to children’s referral, diagnosis and treatment
and to evaluate the impact on this process by vari-
ables such as parental perception of impairment, so-
cial and academic expectations, schools’ attitudes,
clinician characteristics, health insurance and avail-
ability of alternative services.
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